Mankind Pharma Shareholding Pattern
- Market cap
- ₹1.03 lakh crore
- P/E
- 50.4
- P/B
- 6.32
- ROE
- 12.5%
- Dividend yield
- 1.20%
As of 30-JUN-2026, promoters held 72.63% of Mankind Pharma (-0.03 pp from 31-MAR-2026), foreign institutional investors 9.45%, domestic institutions 15.39% and the public 2.53%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 7 October 2026. How this data is compiled.
Mankind Pharma shareholding pattern — frequently asked questions
What is the promoter holding in Mankind Pharma?
Promoters held 72.63% of Mankind Pharma as of 30-JUN-2026, down 0.03 pp from 72.66% in 31-MAR-2026.
How much do FIIs hold in Mankind Pharma?
Foreign institutional investors held 9.45% of Mankind Pharma as of 30-JUN-2026, a change of -0.79 pp from the previous quarter.
How much do domestic institutions hold in Mankind Pharma?
Domestic institutional investors, including mutual funds and insurers, held 15.39% of Mankind Pharma as of 30-JUN-2026 (+0.93 pp from the previous quarter).
Who owns Mankind Pharma?
As of 30-JUN-2026, Mankind Pharma's shareholders were promoters (72.63%), foreign institutional investors 9.45%, domestic institutions 15.39% and the public 2.53%, as filed with the stock exchanges.
Same Data For Peers
Trade Mankind Pharma With ATS
Track MANKIND live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.